Investment thesis
Life science investor making venture, growth, credit and principal investments across the healthcare sector.
Past investments
| Company | Round | Date | Round size |
|---|---|---|---|
| AnaCardio Stockholm, Sweden | Series B | Sep 2026 | €62.5M |
| Breye Therapeutics Denmark | Series A | Sep 2026 | €67.5M |